TickerFactsScreenerDevelopers

Sigyn Therapeutics, Inc. (SIGY) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: $24.5K2014: $99.4K2015: -$82.0K2016: -$691.8K2017: -$2.09M2018: -$3.72M2019: -$9102020: $99.2K2021: -$264.6K2022: -$1.90M2023: -$3.41M2024: -$4.46M-$4.46M
2013Shareholders' Equity (USD)2024
Fiscal YearShareholders' EquityChange YoY
2024-$4.46M-30.6%
2023-$3.41M-79.3%
2022-$1.90M-619.3%
2021-$264.6K-366.8%
2020$99.2K+10998.8%
2019-$910+100.0%
2018-$3.72M-77.4%
2017-$2.09M-202.7%
2016-$691.8K-743.6%
2015-$82.0K-182.5%
2014$99.4K+305.4%
2013$24.5K—